title: Two newborns of heroin-addicted mothers suffering neonatal withdrawal syndrome.
abstract: Neonatal withdrawal syndrome is characterized by non-specific signs and symptoms that occur in infants following in-utero drug exposure. The incidence of neonatal withdrawal syndrome is 16-90% in infants of mothers abusing heroin. Clinical signs of withdrawal syndrome usually occur within the first 48-72 hours after birth. Central nervous system and gastrointestinal system symptoms are the main symptoms. In this case report, two newborns born to the mothers addicted to heroin who suffered neonatal withdrawal syndrome are presented. They were successfully treated with phenobarbital and morphine infusion.
authors.affiliation: Department of Pediatrics, Çukurova University Faculty of Medicine, Adana, Turkey. erenk9@yahoo.com
authors.forename: Eren
authors.initials: E
authors.lastname: Kale-Çekinmez
authors.forename: Birgül
authors.initials: B
authors.lastname: Mutlu
authors.forename: Hacer
authors.initials: H
authors.lastname: Yapıcıoğlu
authors.forename: Ferda
authors.initials: F
authors.lastname: Ozlü
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Asker
authors.forename: Kurthan
authors.initials: K
authors.lastname: Mert
authors.forename: Nejat
authors.initials: N
authors.lastname: Narlı
authors.forename: Mehmet
authors.initials: M
authors.lastname: Satar
mesh_terms: D005260:Female; D006556:Heroin Dependence / Q000150:complications*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007231:Infant, Newborn; D009020:Morphine / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D010634:Phenobarbital / Q000627:therapeutic use*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
chemical_list: D006993:Hypnotics and Sedatives; D009294:Narcotics; D009020:Morphine; D010634:Phenobarbital